Back to Avoro Capital Advisors LLC Avoro Capital Advisors LLC

KRYSKRYS

Showing 8 of 19 quarters

Position history for Avoro Capital Advisors LLCAvoro Capital Advisors LLC's holdings in KRYSTAL BIOTECH INC

Yes. Avoro Capital Advisors holds 2,888,888 shares of KRYS (Krystal Biotech), worth $1.1B, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Avoro Capital Advisors has held KRYS since Q4 2021, across 19 quarterly 13F filings. KRYS is 9.6% of Avoro Capital Advisors' reported 13F portfolio.

Current Value

$1.1B

Current Shares

2.9M

Total Value Change

+$596.4M

Total Shares Change

+266,666

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
2.9M
0.0%
$1.1B9.6%$371.67
0
2026-Q1
Unchanged
2.9M
0.0%
$746.3M7.3%$263.80
0
2025-Q4
Increased
2.9M
+4.0%
$712.2M7.0%$247.88
65
2025-Q3
Increased
2.8M
+4.4%
$490.4M6.3%$176.75
65
2025-Q2
Decreased
2.7M
-2.6%
$365.6M6.4%$138.88
0
2025-Q1
Increased
2.7M
+3.9%
$492.4M7.7%$183.92
64
2024-Q4
Increased
2.6M
+0.3%
$411.8M5.8%$159.80
61
2024-Q3
Increased
2.6M
+7.8%
$477.3M7.0%$177.14
67

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used